Dr Sanjay Agrawal, a renowned pharmaceutical consultant and scientific advisor of Alkomex GBN Pharma Group USA, has recently applied for a patent for a specialized formulation to address chronic kidney disease (CKD) related nutritional deficiencies and improve patient outcomes. This specialized formulation is designed to uniquely delay the necessity for dialysis or renal transplantation, reduce the pill burden, promoting better patient adherence to treatment regimens, slow the progression of CKD and reduce the risk of end-stage renal disease (ESRD).
